Debate Over TPP’s Intellectual Property Protection Provisions Expected Among U.S. Politicians

Washington Post: How the controversy over drug prices could take down Obama’s massive trade deal
“A political firestorm is building over the protections for drug companies in [the Trans Pacific Partnership (TPP)] international trade deal, threatening support for a key piece of the president’s legacy. The chapter addressing the issue, which was posted online Friday by WikiLeaks, grants at least five years of exclusivity to the makers of next-generation biologic medicines for diseases ranging from cancer to rheumatoid arthritis…” (Johnson, 10/9).